Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia
Abstract Background Fluoroquinolone antibiotics are frequently utilized in pediatric oncology patients as prophylaxis or step‐down therapy following broad spectrum beta‐lactam therapy for febrile neutropenia. Concerns regarding neurotoxicity limit the use of these agents. No studies have evaluated t...
Main Authors: | Seth E. Karol, Yilun Sun, Li Tang, Ching‐Hon Pui, Jose Ferrolino, Kim J. Allison, Shane J. Cross, William E. Evans, Kristine R. Crews, Sima Jeha, Joshua Wolf |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3249 |
Similar Items
-
Fluoroquinolone resistance: relation between drug use and evolution of resistance in some Units of the “San Bassiano” hospital from 2007 to 2008
by: Claudia Mascotto, et al.
Published: (2010-06-01) -
Fluoroquinolones: Utilisation and Compliance with WHO Defined Daily Doses
by: Alisha, MASA, et al.
Published: (2021) -
Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea
by: O'Brien Terrence P, et al.
Published: (2003-10-01) -
Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa
by: Lei Zhao, et al.
Published: (2020-08-01) -
Maintaining Fluoroquinolone Class Efficacy: Review of Influencing Factors
by: W. Michael Scheld
Published: (2003-01-01)